Goldman Sachs’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.1M | Buy |
|
|||||
|
2025
Q1 | $499K | Sell |
|
|||||
|
2024
Q4 | $1.67M | Sell |
|
|||||
|
2024
Q3 | $2.42M | Buy |
|
|||||
|
2024
Q2 | $2.3M | Sell |
|
|||||
|
2024
Q1 | $3.04M | Buy |
|
|||||
|
2023
Q4 | $148K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $27.4K | Sell |
|
|||||
|
2022
Q3 | $84K | Sell |
|
|||||
|
2022
Q2 | $258K | Sell |
|
|||||
|
2022
Q1 | $580K | Buy |
|
|||||
|
2021
Q4 | $618K | Buy |
|
|||||
|
2021
Q3 | $225K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $392K | Sell |
|
|||||
|
2020
Q3 | $1.76M | Buy |
|